← Back to Search

Genetic Testing

Genetic Counseling for Family (OPTEC Trial)

N/A
Waitlist Available
Led By Paul Goodfellow
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if universal screening for DNA mismatch repair deficiency can help guide treatment strategies for endometrial cancer patients.

Eligible Conditions
  • Colorectal Cancer
  • Uterine Cancer
  • Endometrial Adenocarcinoma
  • Family

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of endometrial cancer patients with Lynch syndrome
Incidence of tumors with microsatellite instability and/or somatic POLE mutations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Comprehensive LS genetic testingExperimental Treatment4 Interventions
Testing for inherited forms of cancer and tumor sequencing

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,925 Previous Clinical Trials
41,016,999 Total Patients Enrolled
1 Trials studying Family
1,000 Patients Enrolled for Family
Ohio State University Comprehensive Cancer CenterLead Sponsor
340 Previous Clinical Trials
293,493 Total Patients Enrolled
Paul GoodfellowPrincipal InvestigatorOhio State University Comprehensive Cancer Center
1 Previous Clinical Trials
~132 spots leftby Nov 2025